Sage Therapeutics Inc (FRA:SG7)
€ 6.826 -1.132 (-14.22%) Market Cap: 365.22 Mil Enterprise Value: -151.29 Mil PE Ratio: 0 PB Ratio: 0.72 GF Score: 48/100

Q2 2020 SAGE Therapeutics Inc Earnings Call Transcript

Aug 10, 2020 / 12:30PM GMT
Release Date Price: €41.56 (-2.21%)
Operator

Ladies and gentlemen, thank you for standing by, and welcome to the Sage Therapeutics Second Quarter 2020 Financial Results Conference Call. Please be advised that today's conference is being recorded. (Operator Instruction]. I would now like to hand the conference over to your speaker today, Jeff Boyle, Senior Director, Investor Relations. Thank you. Please go ahead, Sir.

Jeff Boyle
Sage Therapeutics, Inc. - Investor Contact

Good morning, and thank you for joining Sage Therapeutics' Second Quarter 2020 Financial Results Conference Call. Before we begin, I encourage everyone to go to the investor and Media section of our website at sagerx.com, where you can find the press release related to today's call as well as the slides that contain supplemental details.

I would like to point out that we will be making forward-looking statements, which are based on our current expectations and beliefs. These statements are subject to certain risks and uncertainties, and our actual results may differ materially. Please consult the risk factors discussed in today's

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot